Analysis of Risk Factors for High Intraocular Pressure and Retinal Detachment Recurrence After Vitrectomy with Silicone Oil Tamponade in Retinal Detachment Patients

Launched by FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY · Feb 10, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at patients who have a specific type of eye condition called rhegmatogenous retinal detachment, which is when the retina pulls away from its normal position. The study aims to find out what factors might lead to high eye pressure or a recurrence of retinal detachment after a common surgical treatment that involves several steps, including removing the vitreous gel inside the eye, using lasers to repair the retina, and placing silicone oil to help keep the retina in place. The researchers will collect information from patients who meet certain criteria, such as being over 18 years old and having a normal eye pressure before surgery, and will follow them for several months after their surgery to see how they are doing.

Eligible participants should be able to understand the study and provide consent, and they should not have any serious eye diseases or infections that could affect the results. During the trial, patients will have their progress monitored at various times after the surgery, and any urgent health issues that arise will be treated. This study is important because it will help doctors better understand how to improve outcomes for patients with retinal detachment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Diagnosed with "rhegmatogenous retinal detachment". 2. Aged over 18 years old, with normal mental and psychological status, regardless of gender.
• • 3. Intraocular pressure of both eyes is less than 21 mmHg before surgery, and having no personal or family history of glaucoma.
• • 4. Cup - to - disc ratio (C/D) in fundus examination is less than 0.5 for both eyes.
• • 5. Those who understand the purpose of this study, sign the "Informed Consent Form" and have a high degree of compliance.
• Exclusion Criteria:
• • - 1. Those with high intraocular pressure before surgery and suffering from ophthalmic diseases such as glaucoma; 3. Those with acute or chronic systemic infections and hematological diseases; 4. Those with a history of mental and psychological diseases; 5. Those with incomplete survey data or unable to cooperate with this research. 5. Those with traumatic rhegmatogenous retinal detachment; 6. Those with active ocular infectious lesions in either eye; 7. Those with severe refractive media opacity (such as corneal nebula, corneal leukoma) in the target eye, which affects imaging examinations during postoperative follow - up.
• • 8. Those with a history of congenital structural abnormalities in the target eye; 9. Those who have undergone vitrectomy for other vitreoretinal diseases in the target eye before screening; 10. Those whom the researchers consider unfit to participate in this clinical trial.